DXM
DXM (dextromethorphan) is a common over-the-counter cough suppressant that is safe at recommended doses but produces dissociative, PCP-like effects when misused in large amounts; combination cough-and-cold products make overdose especially dangerous.
Overview
Dextromethorphan, usually called DXM, is a cough suppressant found in many over-the-counter cold and cough medicines, sold as syrups, capsules, and tablets. At the doses on the label it is a safe, effective, and widely used remedy for temporary coughs. At much higher doses, however, DXM acts as a dissociative drug, producing effects similar to ketamine or PCP, which is why it is sometimes misused — a practice often called 'robotripping.' Because DXM is legal and easy to buy, misuse is most common among adolescents and young adults. A key danger is that many products contain DXM combined with other active ingredients, so taking a large amount to feel DXM's effects also means a dangerous overdose of those other drugs.
Source: MedlinePlus; DEA; peer-reviewed clinical literature
Chemistry & mechanism of action
At normal doses, DXM acts on the brain to suppress the cough reflex. At the much larger doses used recreationally, DXM and its metabolite (dextrorphan) block NMDA glutamate receptors — the same action behind the dissociative effects of ketamine and PCP — producing detachment, distorted perception, and hallucinations. DXM also affects serotonin and adrenaline systems, which is why high doses can raise blood pressure and heart rate and, especially when combined with other serotonergic drugs, can contribute to serotonin syndrome. Users describe dose-dependent 'plateaus,' with effects becoming more intense and dissociative as the dose increases.
Source: Peer-reviewed clinical literature; DEA
Effects
At recommended doses, DXM relieves coughing with few side effects. Misused at high doses, effects are dose-dependent and can include euphoria and restlessness at lower recreational doses, progressing to exaggerated sensations, distorted vision, loss of coordination, and — at the highest doses — intense hallucinations, a sense of leaving the body, and near-total dissociation. Common unwanted effects include nausea and vomiting, dizziness, rapid heartbeat, sweating, high blood pressure, and impaired coordination and judgment.
Source: DEA; MedlinePlus
Risks & harms
DXM is dangerous in several ways when misused. High doses impair coordination and judgment, raising the risk of accidents, and can cause dangerously high blood pressure, rapid heart rate, and — at extreme doses — depressed breathing. The most underappreciated danger is combination products: many cough-and-cold medicines pair DXM with acetaminophen, antihistamines, or decongestants, so taking enough to feel DXM's effects can cause acetaminophen liver toxicity or antihistamine overdose at the same time. Mixing DXM with alcohol or other drugs, or with serotonergic medications (which raises the risk of life-threatening serotonin syndrome), is especially hazardous. Heavy, repeated use can lead to tolerance and dependence, and high doses can trigger psychosis. If an overdose is suspected, contact Poison Control at 1-800-222-1222, or call 911 in an emergency. For help with misuse, the SAMHSA helpline is 1-800-662-4357.
Source: DEA; MedlinePlus; peer-reviewed clinical literature
Legal status (US)
In the United States, dextromethorphan is legal and sold over the counter; it is not a controlled substance under the Controlled Substances Act. The Drug Enforcement Administration lists it as a 'drug of concern' because of its abuse potential. To curb misuse, federal law and many states restrict sales of DXM-containing products to minors, requiring buyers to be 18 or older and sometimes requiring photo identification. Pharmacies and retailers may impose additional limits. Because age-restriction and sales rules vary by state, check current local law. This is general legal information, not legal advice.
Source: DEA; US federal and state law
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling — penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authorityand your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulatein the destination immediately — notthe destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With dissociatives, coordination and judgment are impaired and effects can come in waves — sit or lie down somewhere safe so you don't fall, and don't drive or make decisions until it clears.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown — pending review”Identity
- PubChem CID
- 5360696PubChem PUG-REST ↗ · retrieved 2026-06-18
- IUPAC name
- (1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trienePubChem PUG-REST ↗ · retrieved 2026-06-18
- Molecular formula
- C18H25NOPubChem PUG-REST ↗ · retrieved 2026-06-18
- SMILES
- CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OCPubChem PUG-REST ↗ · retrieved 2026-06-18
- InChIKey
- MKXZASYAUGDDCJ-NJAFHUGGSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
- Synonyms / aliases
- robo, dex, dextromethorphan, d-Methorphan, delta-Methorphan, Dextromorphan, Dextromethorfan, Dextrometorfano, Dextromethorphane, Albutussin, Destrometerfano, DextromethorphanumPubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18
Composition
- Composition
- N/A — single compound (see Identity)
Physical / pill characteristics
- Dosage form
- Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
- Route
- Unknown — pending review
- Shape
- Unknown — pending review
- Color
- Unknown — pending review
- Imprint
- Unknown — pending review
- Score
- Unknown — pending review
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA ↗ · retrieved 2026-06-18
Effects
- Effects
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Risks
- Risks
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Interactions
- Interactions
- Unknown — pending review
Dosage
Pending medical reviewer
